KJ Research, Rosemère, Québec, Canada.
Curr Med Res Opin. 2011 Feb;27(2):449-62. doi: 10.1185/03007995.2010.545813. Epub 2011 Jan 3.
Estimates on the epidemiology of chronic non-cancer pain vary widely throughout Europe. It is unclear whether this variation reflects true population differences or methodological factors. Such epidemiological information supports European decision makers in allocating healthcare resources.
Pan-Europe epidemiological data about chronic non-cancer pain was obtained using systematic review principles in searching and summarising results.
Multiple databases (MEDLINE, EMBASE, Cochrane Library, CRD Databases, and GIN) were systematically searched for primary studies containing epidemiological data on chronic non-cancer pain in Europe excluding studies that solely concerned migraines, headaches and pain associated with specific disease conditions. The studies were prioritised according to quality, recency and validity.
Eighteen research questions concerning aspects of chronic pain included: prevalence; incidence; pain treatments, control and compliance; treatment satisfaction; and quality of life and economic impacts.
The search yielded 16 619 references and 45 were relevant to Europe. Studies for each question were selected that provided the most recent, representative and valid data. There was a clear lack of studies concerning chronic non-cancer pain in Europe as a whole. The 1-month prevalence of moderate-to-severe non-cancer chronic pain was 19%. Chronic pain significantly impacted on patient-perceived health status, affected everyday activities including economic pursuits and personal relationships, and was significantly associated with depressive symptoms. The majority relied on drugs for pain control and NSAIDs were the most frequent drug choice. Despite pain medications, a large proportion had inadequate pain control.
To the authors' knowledge this is the most comprehensive literature review on epidemiological data in this field. It is clear that chronic pain has a dramatic impact on European society. Since chronic non-cancer pain is treated differently from cancer-related pain, the lack of data in this area clearly underlines the need for decision makers in healthcare to gather further epidemiological data.
欧洲各地对慢性非癌症疼痛的流行病学估计差异很大。这种差异是否反映了真实的人群差异或方法学因素尚不清楚。这种流行病学信息支持欧洲决策者分配医疗保健资源。
通过系统搜索和总结结果,获得欧洲慢性非癌症疼痛的泛欧流行病学数据。
使用系统评价原则,在多个数据库(MEDLINE、EMBASE、Cochrane 图书馆、CRD 数据库和 GIN)中系统搜索关于欧洲慢性非癌症疼痛的流行病学数据的原始研究,不包括仅涉及偏头痛、头痛和与特定疾病状况相关的疼痛的研究。根据质量、时效性和有效性对研究进行优先级排序。
共提出了 18 个关于慢性疼痛各个方面的研究问题,包括:患病率;发病率;疼痛治疗、控制和依从性;治疗满意度;生活质量和经济影响。
搜索结果产生了 16619 条参考文献,其中 45 条与欧洲有关。选择了每个问题的研究,这些研究提供了最新、最具代表性和最有效的数据。关于整个欧洲的慢性非癌症疼痛的研究明显缺乏。1 个月时中度至重度非癌症慢性疼痛的患病率为 19%。慢性疼痛显著影响患者感知的健康状况,影响日常活动,包括经济追求和人际关系,并与抑郁症状显著相关。大多数人依赖药物控制疼痛,非甾体抗炎药是最常见的药物选择。尽管使用了止痛药,但仍有很大一部分人疼痛控制不理想。
据作者所知,这是该领域最全面的流行病学数据文献综述。很明显,慢性疼痛对欧洲社会有巨大影响。由于慢性非癌症疼痛的治疗方法与癌症相关疼痛不同,因此该领域缺乏数据清楚地强调了医疗保健决策者进一步收集流行病学数据的必要性。